The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis

Endocrine Journal

Volumn 60, Issue 2, 2013, Pages 185-189

  Yang, Jing ^a   Zhong, Jing ^a   Xiao, Xin Hua ^a   Zhou, Ling Zhi ^a   Chen, Ya Jun ^a   Liu, Jiang Hua ^a   Cao, Ren Xian ^a   Wen, Ge Bo ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Agranulocytosis; Antithyroid drug; Bone marrow characteristic; Hyperthyroidism

Indexed keywords

ANTITHYROID AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ADVERSE OUTCOME; AGRANULOCYTOSIS; ARTICLE; BONE MARROW; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DYSMATURITY; FEMALE; FEVER; GRANULOCYTE PRECURSOR; HUMAN; HYPERPLASIA; HYPOPLASIA; MALE; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT FAILURE;

ADULT; AGRANULOCYTOSIS; ANTITHYROID AGENTS; BONE MARROW; CELL DIFFERENTIATION; CHINA; FEMALE; FEVER; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE PRECURSOR CELLS; HOSPITALS, UNIVERSITY; HUMANS; HYPERTHYROIDISM; MALE; METHIMAZOLE; MIDDLE AGED; PROGNOSIS; PROPYLTHIOURACIL; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84874594014     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0332     Document Type: Article

References (24)

1. Cooper DS (2005) Antithyroid drugs. N Engl J Med 352:905-917.
2. Thomas D, Moisidis A, Tsiakalos A, Alexandraki K, Syriou V, et al. (2008) Antithyroid drug-induced aplastic anemia. Thyroid 18:1043-1048.
3. Tajiri J, Noguchi S (2004) Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis. Thyroid 14:459-462.
4. Sheng WH, Hung CC, Chen YC, Fang CT, Hsieh SM, et al. (1999) Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections. QJM 92:455-461.
5. Andres E, Zimmer J, Mecili M, Weitten T, Alt M, et al. (2011) Clinical presentation and management of druginduced agranulocytosis. Expert Rev Hematol 4:143-151.
6. Douer D, Eisenstein Z (1988) Methimazole-induced agranulocytosis: growth inhibition of myeloid progenitor cells by the patient's serum. Eur J Haematol 40:91-94.
7. Sun MT, Tsai CH, Shih KC (2009) Antithyroid drug-induced agranulocytosis. J Chin Med Assoc 72:438-441.
8. Tajiri J, Noguchi S, Okamura S, Morita M, Tamaru M, et al. (1993) Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia. Arch Intern Med 153:509-514.
9. Tamai H, Mukuta T, Matsubayashi S, Fukata S, Komaki G, et al. (1993) Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF). J Clin Endocrinol Metab 77:1356-1360.
10. Julia A, Olona M, Bueno J, Revilla E, Rossello J, et al. (1991) Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes. Br J Haematol 79:366-371.
11. Waldhauser L, Uetrecht J (1991) Oxidation of propylthiouracil to reactive metabolites by activated neutrophils. Implications for agranulocytosis. Drug Metab Dispos 19:354-359.
12. Akamizu T, Ozaki S, Hiratani H, Uesugi H, Sobajima J, et al. (2002) Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity. Clin Exp Immunol 127:92-98.
13. Harper L, Chin L, Daykin J, Allahabadia A, Heward J, et al. (2004) Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease. Clin Endocrinol (Oxf) 60:671-675.
14. Tajiri J, Noguchi S, Murakami T, Murakami N (1990) Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med 150:621-624.
15. Watanabe N, Narimatsu H, Noh JY, Yamaguchi T, Kobayashi K, et al. (2012) Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease. J Clin Endocrinol Metab 97:E49-53.
16. Biswas N, Ahn YH, Goldman JM, Schwartz JM (1991) Aplastic anemia associated with antithyroid drugs. Am J Med Sci 301:190-194.
17. Moreb J, Shemesh O, Shilo S, Manor C, Hershko C (1983) Transient methimazole-induced bone marrow aplasia: in vitro evidence for a humoral mechanism of bone marrow suppression. Acta Haematol 69:127-131.
18. Yamamoto A, Katayama Y, Tomiyama K, Hosoai H, Hirata F, et al. (2004) Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis. Thyroid 14:231-235.
19. Cooper DS, Goldminz D, Levin AA, Ladenson PW, Daniels GH, et al. (1983) Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med 98:26-29.
20. Yang J, Zhong J, Zhou LZ, Hong T, Xiao XH, et al. (2012) Sudden onset agranulocytosis and hepatotoxicity after taking methimazole. Intern Med 51:2189-2192.
21. Andres E, Kurtz JE, Perrin AE, Dufour P, Schlienger JL, et al. (2001) Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis. QJM 94:423-428.
22. Fukata S, Kuma K, Sugawara M (1999) Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid 9:29-31.
23. Tajiri J, Noguchi S (2005) Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy? Thyroid 15:292-297.
24. Lieschke GJ, Burgess AW (1992) Granulocyte colonystimulating factor and granulocyte-macrophage colony-stimulating factor (first of two parts). N Engl J Med 327:28-35.